Anticancer drugs are not well tolerated in all older patients with cancer
Summary: Studies on new anticancer drugs often inappropriately conclude that these treatments are well tolerated and feasible in the older population with cancer, despite the drug being investigated in only a selection of healthy older patients who are not representative of the true older population...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-10-01
|
| Series: | The Lancet. Healthy Longevity |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666756820300015 |